Survival rates dropped to 61% at 2 years and 45.5% at 5 years in transcatheter aortic valve implant patients, according to a new analysis of U.K. registry data published in the journal JACC: Cardiovascular Interventions.
The survival rate for high-risk patients with transcatheter aortic valve implants surpassed 61% at 3 years and drops to 45.5% at 5 years, according to a new analysis of data from the U.K. Transcatheter Aortic Valve Implantation Registry.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1JkA8E8
Cap comentari:
Publica un comentari a l'entrada